<DOC>
	<DOCNO>NCT00757874</DOCNO>
	<brief_summary>Lichen Sclerosus inflammatory skin condition affect mostly genital area person age , gender race . The frequent complaint itchiness vulva pain may also occur . Some woman experience symptom . However , important treat condition since may increase cause important scarring deformity . In less 5 % case , cancer may develop . Lichen Sclerosus chronic disease control cure . Topical corticosteroid usual treatment condition . Though treatment generally well tolerate , patient may present sufficient response may develop mainly local rarely systemic side effect . In perspective , alternative treatment would beneficial . Tacrolimus , topical immunomodulator approve treatment atopic eczema show efficacy treatment vulvar lichen sclerosus limit number patient . Tacrolimus act non-steroidal anti-inflammatory agent ( NSAI ) without cause usual side effect see prolong use topical corticosteroid . This study design evaluate safety efficacy tacrolimus treat vulvar lichen sclerosus compare standard topical corticosteroid treatment .</brief_summary>
	<brief_title>Tacrolimus Versus Clobetasol Propionate Treatment Vulvar Lichen Sclerosus</brief_title>
	<detailed_description />
	<mesh_term>Lichen Sclerosus et Atrophicus</mesh_term>
	<mesh_term>Vulvar Lichen Sclerosus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Female , 2 year old Medical diagnosis vulvar lichen sclerosus Received treatment last 4 week Who receive topical steroid , tacrolimus pimecrolimus 4 last week . Who immunocompromised Who history intraepithelial neoplasia anogenital carcinoma Who active vulvar infection ( herpes , condylomas , vaginitis ) Who hypersensitive tacrolimus , pimecrolimus corticosteroid Who physical limitation cause difficulty apply cream Who wear diaper Who present Hyperkeratotic Vulvar Lichen Sclerosus</criteria>
	<gender>Female</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Female urogenital disease</keyword>
	<keyword>skin disease</keyword>
</DOC>